Editorial comment on "Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective"

Pediatr Allergy Immunol. 2023 Mar;34(3):e13933. doi: 10.1111/pai.13933.

Authors

Antonio Marzollo¹, Carmen Riggioni², Francesco Cinetto^{3

4}

Affiliations

¹ Pediatric Hematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Padua, Italy.
² Allergy, Immunology and Rheumatology Division, Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
³ Rare Diseases Referral Center, Internal Medicine 1, Ca' Foncello Hospital, Treviso, Italy.
⁴ Department of Medicine - DIMED, University of Padova, Padova, Italy.

PMID: 36974651
DOI: 10.1111/pai.13933

No abstract available

Publication types

Editorial

MeSH terms

Birth Weight
Female
Humans
Immunomodulating Agents*
Infant, Newborn
Pregnancy

Substances

Immunomodulating Agents